Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Treasury Shares of $671147.0 for Q1 2026, up 121.2% year-over-year from $303417.0 in Q1 2025, and up 92.31% quarter-over-quarter from $348994.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Treasury Shares for 3 consecutive years, with $671147.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 121.2% year-over-year to $671147.0; the TTM figure through Mar 2026 stood at $671147.0 (up 121.2% YoY), while the FY2025 annual figure was $348994.0, up 66.19% from the prior year.
- Treasury Shares improved to $671147.0 in Q1 2026 per XENE's latest filing, from $348994.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $671147.0 in Q1 2026 and bottomed at $192000.0 in Q1 2024.
- Historically, Treasury Shares has averaged $306766.3 across 3 years, with a median of $303417.0 in 2025.
- Annual changes were most pronounced in 2025 — Treasury Shares jumped 49.23% — and 2026, when it soared 121.2%.
- Xenon Pharmaceuticals' Treasury Shares stood at $210000.0 in 2024, then soared by 66.19% to $348994.0 in 2025, then surged by 92.31% to $671147.0 in 2026.
- Business Quant data shows XENE's Treasury Shares at $671147.0 in Q1 2026, $348994.0 in Q4 2025, and $313382.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | 696,231.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 696,231.00 |
| Jun 30, 2026 | 696,231.00 |
| Mar 31, 2026 | 671,147.00 |
| Mar 31, 2026 | 671,147.00 |
| Dec 31, 2025 | 348,994.00 |
| Dec 31, 2025 | 348,994.00 |
| Sep 30, 2025 | 313,382.00 |
| Sep 30, 2025 | 313,382.00 |
| Jun 30, 2025 | 316,957.00 |
| Jun 30, 2025 | 316,957.00 |
| Mar 31, 2025 | 303,417.00 |
| Mar 31, 2025 | 303,417.00 |
| Dec 31, 2024 | 210,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |